Bioitech is a company specializing in the transformation of raw materials and in the production of biotechnological products in the medical sector.

Bioitech was established in 2009, however its know-how on chemical crosslinking has been developing since 1998 and is, to date, among the few companies worldwide to operate in multiple areas of medicine by applying crosslinking technology in the transformation of raw materials for specific medical applications and to increase the performance of active ingredients.

Bioitech has developed exclusive products in medicine, such as the first powdered raw material based on cross-linked hyaluronic acid for ophthalmic use and the first injectable filler based on cross-linked carboxymethyl cellulose on the market.